ebm.bmj

Evidence maps: a tool to guide research agenda setting

Correspondence to Dr Fares Alahdab, Mayo Clinic Minnesota, Rochester MN 55905, USA; alahdab.fares{at}mayo.edu, fares.alahdab{at}gmail.com A surprisingly huge proportion of medical research still shows ...
ebm.bmj

BMJ Evidence-Based Medicine

BMJ Evidence-Based Medicine (BMJ EBM) publishes original evidence-based research, insights and opinions on what matters for health care. We focus on the tools, methods, and concepts that are basic and ...
ebm.bmj

Rapid review methods series: Guidance on the use of supportive software

This paper is part of a series of methodological guidance from the Cochrane Rapid Reviews Methods Group. Rapid reviews (RRs) use modified systematic review methods to accelerate the review process ...
ebm.bmj

Rapid reviews methods series: Guidance on assessing the certainty of evidence

This paper is part of a series of methodological guidance from the Cochrane Rapid Reviews Methods Group. Rapid reviews (RRs) use modified systematic review methods to accelerate the review process ...
ebm.bmj

Mapping drug-class associations with sudden cardiac arrest in the outpatient setting: an exploratory population-based case-control analysis

Objectives To map the risk profile of drug classes at the population level by identifying associations between newly prescribed reimbursed drugs and sudden cardiac arrest (SCA), thereby providing a ...
ebm.bmj

Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances

Objectives Alteplase is commonly recommended for acute ischaemic stroke within 4.5 hours after stroke onset. The Third European Cooperative Acute Stroke Study (ECASS III) is the only trial reporting ...
ebm.bmj

Efficacy of smartphone apps used alone or with traditional interventions for smoking cessation: a systematic review and meta-analysis

Objectives To assess the efficacy of smartphone apps for smoking cessation (SC) used alone or combined with traditional interventions, and to determine whether apps based on psychological-behavioural ...
ebm.bmj

Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision ...

Introduction: High-quality randomised controlled trials (RCTs) provide the most reliable evidence on the comparative efficacy of new medicines. However, non-randomised studies (NRS) are increasingly ...
BMJ Evidence-Based Medicine

Methylphenidate denied access to WHO’s list of essential medicines for the third time

Attention-deficit/hyperactivity disorder (ADHD) affects 3%–5% of children and about 2.5% of adults, though prevalence varies across regions.1 The psychostimulant methylphenidate is widely used as ...
ebm.bmj

Evaluating the performance of maternal risk factors in predicting gestational diabetes mellitus: a systematic review and meta-analysis

Objective To systematically consolidate the most consistently applicable risk factors and assess their predictive performance for gestational diabetes mellitus (GDM) prediction. Design Systematic ...
ebm.bmj

Environmental Lessons Learned and Applied (ELLA): a new framework for identifying, prioritising and implementing decarbonisation interventions in clinical care pathways

A multidisciplinary framework for designing rapidly deployable, scalable and context-specific decarbonisation interventions for clinical care has been developed within the National Health Service, ...